Prevalence of IEM Among Upper GIT Symptoms
Prevalence of Ineffective Esophageal Motility Among Upper Gastrointestinal Symptoms
1 other identifier
observational
50
0 countries
N/A
Brief Summary
- detect the prevalence of IEM among upper git symptom .
- clarify the role of HRM in diagnosis of refractory upper GIT symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJune 22, 2023
June 1, 2023
1 year
June 12, 2023
June 12, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
detect the prevalence of IEM among upper git symptom
detect the prevalence of IEM among upper git symptom
Basline
clarify the role of HRM in diagnosis of refractory upper GIT symptoms
clarify the role of HRM in diagnosis of refractory upper GIT symptoms
Baseline
Eligibility Criteria
patient bove the age of 18 years old presented with upper git symptoms
You may qualify if:
- patient bove the age of 18 years old
- All patient presented with upper git symptoms
You may not qualify if:
- Patients \<18 years old 2- patient with known obstructive esophageal disease by endoscopy (i.e. cancer, Stricture) 3- systemic illnesses, scleroderma 4- esophagogastric junction (EGJ) outflow obstruction (mean integrated relaxation pressure ≥15 mmHg).
- achalasia, 6-Patient who had previouslyundergone esophageal surgery (i.e. antireflux surgery or myotomy) or endoscopic intervention (i.e. transoral fundoplication) were excluded.
- Patient with atypical (ENT or respiratory) symptoms only . 8-Patient with oropharyngeal dysphagia without associated esophageal symptoms .
- patient receiving chemotherapy or radiotherapy 10-patient with thyroid disfunction 11- patient with pulber palsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Zhuang QJ, Tan ND, Zhang MY, Chen SF, Luo Y, Xiao YL. Ineffective esophageal motility in Chicago Classification version 4.0 better predicts abnormal acid exposure. Esophagus. 2022 Jan;19(1):197-203. doi: 10.1007/s10388-021-00867-5. Epub 2021 Aug 10.
PMID: 34378104BACKGROUNDSchlottmann F, Patti MG. Primary Esophageal Motility Disorders: Beyond Achalasia. Int J Mol Sci. 2017 Jun 30;18(7):1399. doi: 10.3390/ijms18071399.
PMID: 28665309BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
June 12, 2023
First Posted
June 22, 2023
Study Start
August 1, 2023
Primary Completion
August 1, 2024
Study Completion
September 1, 2024
Last Updated
June 22, 2023
Record last verified: 2023-06